mic b mic species strain mg l mg l mg l enterococcus faecium (ATCC)
Structured Review
Mic B Mic Species Strain Mg L Mg L Mg L Enterococcus Faecium, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 17831 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enterococcus+species/MIC/us12371429-1340-3-52
Average 99 stars, based on 17831 article reviews
Images
Related Articles
other:Article Title: Drug for the treatment of diseases caused by bacteria Article Snippet: MIC (μg/ml) Strains MRSA Strains VRSA Strain MSSA Compound Resistance VT-V-18 VT-E-25 VT-A-199 VT-P-82 SA77 SA85 Control:Article Title: Prevalence and characterization of Staphylococcus aureus isolated from patients with aerobic vaginitis in Shenzhen, Southern China Article Snippet: As the drug sensitivity range for vaginal detergent is not yet clearly defined, we followed methods from a previous study [ ].Susceptibility was assessed by comparing the minimum inhibitory concentrations (MICs) of the isolates against the quality control strain ATCC 25,923. .. Isolates were classified as “Resistant (R)” if their Article Title: Ethambutol resistance in Mycobacterium avium-intracellulare is associated with mutations in the embA–embB promoter and embB Article Snippet: .. The Inhibition:Article Title: Enhanced anti-ESKAPE pathogen and antibiofilm activities of Korean red ginseng-derived silver nanoparticles via membrane deformation: LC/HRMS profiling and dynamic correlations Article Snippet: .. Klebsiella pneumoniae Staphylococcus aureus Pseudomonas aeruginosa ATCC 90902 Escherichia coli 0157 ATTCC 700728 Enterobacter spp. Acinetobacter spp. Enterococcus spp. Inhibition percentage HO3 extract 30.232 ± 0.15 58.325 ± 0.25 62.205 ± 0.35 48.507 ± 0.55 60.308 ± 1.07 72.052 ± 0.12 80.25 ± 0.17 AgNPs 40.01 ± 0.15 70.55 ± 0.15 75.22 ± 0.24 65.12 ± 1.15 75.308 ± 1.17 85.052 ± 0.27 95.22 ± 0.24 Ciprofloxacin (5 μg/mL) – 98.32 ± 0.12 98.20 ± 0.52 96.56 ± 1.13 – – – Vancomycin (30 μg/mL) 98.10 ± 0.27 – – – – 98.20 ± 0.44 Imipenem (10 μg/mL) 90.12 ± 0.22 92.30 ± 0.55 94.15 ± 0.38 Concentration Assay:Article Title: Enhanced anti-ESKAPE pathogen and antibiofilm activities of Korean red ginseng-derived silver nanoparticles via membrane deformation: LC/HRMS profiling and dynamic correlations Article Snippet: .. Klebsiella pneumoniae Staphylococcus aureus Pseudomonas aeruginosa ATCC 90902 Escherichia coli 0157 ATTCC 700728 Enterobacter spp. Acinetobacter spp. Enterococcus spp. Inhibition percentage HO3 extract 30.232 ± 0.15 58.325 ± 0.25 62.205 ± 0.35 48.507 ± 0.55 60.308 ± 1.07 72.052 ± 0.12 80.25 ± 0.17 AgNPs 40.01 ± 0.15 70.55 ± 0.15 75.22 ± 0.24 65.12 ± 1.15 75.308 ± 1.17 85.052 ± 0.27 95.22 ± 0.24 Ciprofloxacin (5 μg/mL) – 98.32 ± 0.12 98.20 ± 0.52 96.56 ± 1.13 – – – Vancomycin (30 μg/mL) 98.10 ± 0.27 – – – – 98.20 ± 0.44 Imipenem (10 μg/mL) 90.12 ± 0.22 92.30 ± 0.55 94.15 ± 0.38 Activity Assay:Article Title: Characterization of Proline-Rich Antimicrobial Peptides with SbmA Transporter-Dependent and Independent Antimicrobial Activity toward Klebsiella pneumoniae . Article Snippet: .. In contrast, PR-39 exhibited reduced antimicrobial activity at room temperature, with a 2-fold increase in Membrane:Article Title: Characterization of Proline-Rich Antimicrobial Peptides with SbmA Transporter-Dependent and Independent Antimicrobial Activity toward Klebsiella pneumoniae . Article Snippet: .. In contrast, PR-39 exhibited reduced antimicrobial activity at room temperature, with a 2-fold increase in |
